SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
This Form 8-K Current Report, dated June 22, 2018, covers events occurring at ChromaDex Corporation's 2018 Annual Meeting of Stockholders. The filing details the approval of corporate governance matters, the ratification of the independent auditor, and significant amendments to executive compensation agreements.
Key Financial Metrics
This filing is a current report regarding corporate governance and executive compensation; it does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes and Executive Compensation
On June 22, 2018, the Company executed several material changes regarding executive leadership and equity plans:
- CEO Compensation (Robert Fried): An Amended and Restated Executive Employment Agreement was signed.
- Base Salary: $450,000 annually effective June 22, 2018, increasing to $500,000 starting in fiscal year 2019.
- Performance Bonus (FY2019+): Target of 60% of base salary, with a threshold of 30% and a maximum of 90%.
- Equity Grant: Option to purchase 744,097 shares of common stock. Vesting schedule: one-third on June 22, 2019, with the remainder vesting monthly over 24 months (fully vested by June 22, 2021).
- Restricted Stock: Grant of 166,667 fully-vested shares approved by the Compensation Committee on June 22, 2018. Additional potential grant of up to 333,333 shares upon achievement of performance goals.
- Severance: In the event of termination without cause or resignation for good reason, Mr. Fried is eligible for 18 months of base salary continuation, 12 months of COBRA premiums, and accelerated vesting of equity.
- Executive Chairman (Frank L. Jaksch, Jr.): An amendment to his employment agreement was executed, formally designating him as Executive Chairman with duties customary to that position.
- Equity Plan Approval: Stockholders approved the amendment to the ChromaDex Corporation 2017 Equity Incentive Plan.
Stockholder Vote Results
The following matters were submitted to a vote at the Annual Meeting held on June 22, 2018:
- Proposal 1 (Election of Directors): All eight nominees (Frank L. Jaksch Jr., Stephen Block, Jeff Baxter, Robert Fried, Kurt Gustafson, Steven Rubin, Wendy Yu, and Tony Lau) were elected. Votes ranged from approximately 28.5 million to 29.0 million "For" votes.
- Proposal 2 (Equity Plan Amendment): Approved with 25,264,898 votes "For" and 3,322,391 "Against".
- Proposal 3 (Auditor Ratification): Marcum LLP was ratified with 47,102,267 votes "For" and 205,070 "Against".
- Proposal 4 (Say-on-Pay): Advisory approval of executive compensation received 26,844,299 votes "For" and 2,171,129 "Against".
Outlook, Risks, and Contingencies
The filing does not provide specific forward-looking guidance, risk factors, or contingencies beyond the standard terms of the executive employment agreements. The primary contingency noted is the performance-based nature of the CEO's bonus and restricted stock grants, which are subject to Board determination and specific performance metrics.
Investor Verification Checklist
- Verify the full text of the Amended and Restated Executive Employment Agreement (Exhibit 10.1) for specific performance metrics defining the CEO's bonus.
- Review the Amended 2017 Equity Incentive Plan (Exhibit 99.1) to understand the total share pool available for future grants.
- Confirm the specific performance goals required for the potential grant of up to 333,333 additional restricted shares to the CEO.
- Check subsequent filings for the actual vesting dates and exercise prices of the 744,097 stock options granted to the CEO.